SBSB
CME icon

Sullivan, Bruyette, Speros & Blaney’s CME Group CME Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$233K Sell
1,140
-11
-1% -$2.17K 0.01% 277
2020
Q4 		$210K Buy
1,151
+179
+18% +$30.4K 0.01% 275
2020
Q3 		$163K Sell
972
-98
-9% -$16.5K 0.01% 275
2020
Q2 		$174K Hold
1,070
– – 0.01% 257
2020
Q1 		$185K Hold
1,070
– – 0.01% 216
2019
Q4 		$215K Buy
1,070
+98
+10% +$20.1K 0.01% 239
2019
Q3 		$205K Buy
+972
New +$203K 0.01% 232

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's CME Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its CME Group (CME) stake by 0.96% in Q1 2021, selling an estimated $2.17K and leaving 1,140 shares worth $233K. The position accounts for 0.01% of the portfolio, ranked #277.

Sullivan, Bruyette, Speros & Blaney first reported a position in CME in Q3 2019 and has held it in 7 quarters since. 1,063 funds tracked by Wall St. Rank hold CME as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 1,140 shares of CME Group worth $233K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 11 CME Group shares in Q1 2021, an estimated $2.17K.
  • CME Group made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #277 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in CME Group in Q3 2019 and has held it in 7 quarters since.
  • 1,063 funds tracked by Wall St. Rank held CME Group as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.